These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Design, synthesis and biological evaluation of aryl pyrimidine derivatives as potential leishmanicidal agents. Suryawanshi SN, Kumar S, Shivahare R, Pandey S, Tiwari A, Gupta S. Bioorg Med Chem Lett; 2013 Sep 15; 23(18):5235-8. PubMed ID: 23910597 [Abstract] [Full Text] [Related]
4. Synthesis and biological evaluation of ferrocenylquinoline as a potential antileishmanial agent. Yousuf M, Mukherjee D, Pal A, Dey S, Mandal S, Pal C, Adhikari S. ChemMedChem; 2015 Mar 15; 10(3):546-54. PubMed ID: 25619822 [Abstract] [Full Text] [Related]
6. Synthesis and evaluation of new furanyl and thiophenyl azoles as antileishmanial agents. Marrapu VK, Mittal M, Shivahare R, Gupta S, Bhandari K. Eur J Med Chem; 2011 May 15; 46(5):1694-700. PubMed ID: 21385661 [Abstract] [Full Text] [Related]
8. Structure-activity relationships and mechanistic studies of novel mitochondria-targeted, leishmanicidal derivatives of the 4-aminostyrylquinoline scaffold. Staderini M, Piquero M, Abengózar MÁ, Nachér-Vázquez M, Romanelli G, López-Alvarado P, Rivas L, Bolognesi ML, Menéndez JC. Eur J Med Chem; 2019 Jun 01; 171():38-53. PubMed ID: 30904756 [Abstract] [Full Text] [Related]
9. Synthesis and characterization of quinoline-carbaldehyde derivatives as novel inhibitors for leishmanial methionine aminopeptidase 1. Bhat SY, Jagruthi P, Srinivas A, Arifuddin M, Qureshi IA. Eur J Med Chem; 2020 Jan 15; 186():111860. PubMed ID: 31759728 [Abstract] [Full Text] [Related]
10. Synthesis and biological evaluation of 2-arylbenzimidazoles targeting Leishmania donovani. Keurulainen L, Siiskonen A, Nasereddin A, Kopelyanskiy D, Sacerdoti-Sierra N, Leino TO, Tammela P, Yli-Kauhaluoma J, Jaffe CL, Kiuru P. Bioorg Med Chem Lett; 2015 May 01; 25(9):1933-7. PubMed ID: 25827525 [Abstract] [Full Text] [Related]
12. Synthesis and biological evaluation of polyhydroxylated oxindole derivatives as potential antileishmanial agent. Yousuf M, Mukherjee D, Dey S, Chatterjee S, Pal A, Sarkar B, Pal C, Adhikari S. Bioorg Med Chem Lett; 2018 Apr 01; 28(6):1056-1062. PubMed ID: 29478704 [Abstract] [Full Text] [Related]
13. Design, synthesis and biological evaluation of piperazinyl-β-carbolinederivatives as anti-leishmanial agents. Ashok P, Chander S, Smith TK, Sankaranarayanan M. Eur J Med Chem; 2018 Apr 25; 150():559-566. PubMed ID: 29549840 [Abstract] [Full Text] [Related]
16. Eugenol derived immunomodulatory molecules against visceral leishmaniasis. Charan Raja MR, Velappan AB, Chellappan D, Debnath J, Kar Mahapatra S. Eur J Med Chem; 2017 Oct 20; 139():503-518. PubMed ID: 28826085 [Abstract] [Full Text] [Related]
17. Effect of pyrazoloquinoline derivatives on the growth of Leishmania donovani promastigotes. Al-Qahtani A, Siddiqui YM, Bekhit AA, El-Sayed OA, Aboul-Enein HY, Al-Ahdalb MN. Arch Pharm (Weinheim); 2005 Oct 20; 338(10):484-7. PubMed ID: 16211660 [Abstract] [Full Text] [Related]
18. Design, Synthesis and Antileishmanial Activity of Naphthotriazolyl-4- Oxoquinolines. Oliveira VG, Dos Santos Faiões V, Gonçalves GBR, Lima MFO, Boechat FCS, Cunha AC, de Andrade-Neto VV, de C da Silva F, Torres-Santos EC, de Souza MCBV. Curr Top Med Chem; 2018 Oct 20; 18(17):1454-1464. PubMed ID: 30277154 [Abstract] [Full Text] [Related]
19. Anti-Leishmanial and Cytotoxic Activities of a Series of Maleimides: Synthesis, Biological Evaluation and Structure-Activity Relationship. Fan Y, Lu Y, Chen X, Tekwani B, Li XC, Shen Y. Molecules; 2018 Nov 05; 23(11):. PubMed ID: 30400596 [Abstract] [Full Text] [Related]
20. Phase transfer catalyzed synthesis of bis-quinolines: antileishmanial activity in experimental visceral leishmaniasis and in vitro antibacterial evaluation. Palit P, Paira P, Hazra A, Banerjee S, Gupta AD, Dastidar SG, Mondal NB. Eur J Med Chem; 2009 Feb 05; 44(2):845-53. PubMed ID: 18538452 [Abstract] [Full Text] [Related] Page: [Next] [New Search]